EVIO Applies for Adult-Use Cannabis Testing License

Cannabis Investing News

EVIO announced its Massachusetts laboratory submitted its license application to the state’s Cannabis Control Commission to become an approved adult-use cannabis testing facility.

EVIO (OTCQB:EVIO) announced its Massachusetts laboratory submitted its license application to the state’s Cannabis Control Commission to become an approved adult-use cannabis testing facility.

As quoted in the press release:

EVIO, a leading provider of cannabis testing and scientific research for the regulated cannabis industry in North America, announced that its Massachusetts lab has submitted its license application to the state’s Cannabis Control Commission and is seeking approval to be licensed as an independent testing laboratory under the Commission’s recently adopted adult use regulations. This is on the heels of the recent announcement of the lab receiving ISO 17025 accreditation.

Massachusetts law requires that all recreational marijuana products bear a seal showing they have been tested by a Commission-licensed independent laboratory for contaminants and potency levels.

“With the cannabis industry continuing to ramp up in Massachusetts, the lab is poised to play a major role being one of only three labs that have started the licensing process,” said Lori Glauser, COO of EVIO. “We are preparing for the rapidly increased demand for testing services as the Commonwealth’s adult-use cannabis market is expected to exceed $1 billion by 2021.”

Click here to read the full press release.

The Conversation (0)
×